A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

NCT00219102 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
336
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis